{"id":"https://openalex.org/W2913106735","doi":"https://doi.org/10.1002/ajh.25434","title":"Using an old test for new tricks: Measuring direct oral anti\u2010Xa drug levels by conventional heparin\u2010calibrated anti\u2010Xa assay","display_name":"Using an old test for new tricks: Measuring direct oral anti\u2010Xa drug levels by conventional heparin\u2010calibrated anti\u2010Xa assay","publication_year":2019,"publication_date":"2019-02-08","ids":{"openalex":"https://openalex.org/W2913106735","doi":"https://doi.org/10.1002/ajh.25434","mag":"2913106735","pmid":"https://pubmed.ncbi.nlm.nih.gov/30734369","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8668051"},"language":"en","primary_location":{"id":"doi:10.1002/ajh.25434","doi":"https://doi.org/10.1002/ajh.25434","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ajh.25434","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.25434","source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.25434","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021756706","display_name":"Cheryl L. Maier","orcid":"https://orcid.org/0000-0003-4044-2674","observed_orcids":["https://orcid.org/0000-0003-4044-2674"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cheryl L. Maier","raw_affiliation_strings":["Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia"],"raw_orcid":"https://orcid.org/0000-0003-4044-2674","affiliations":[{"raw_affiliation_string":"Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024815763","display_name":"William H. Asbury","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800556163","display_name":"Emory University Hospital","ror":"https://ror.org/05dm4ck87","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I2800556163"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William H. Asbury","raw_affiliation_strings":["Department of Pharmacy, Emory University Hospital, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Emory University Hospital, Atlanta, Georgia","institution_ids":["https://openalex.org/I2800556163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108483445","display_name":"Alexander Duncan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Duncan","raw_affiliation_strings":["Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia","Special Coagulation Laboratory, Emory Medical Laboratory, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]},{"raw_affiliation_string":"Special Coagulation Laboratory, Emory Medical Laboratory, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059080524","display_name":"Adele Robbins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800556163","display_name":"Emory University Hospital","ror":"https://ror.org/05dm4ck87","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I2800556163"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adele Robbins","raw_affiliation_strings":["Department of Pharmacy, Emory University Hospital, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Emory University Hospital, Atlanta, Georgia","institution_ids":["https://openalex.org/I2800556163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021124901","display_name":"Ann Ingle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann Ingle","raw_affiliation_strings":["Special Coagulation Laboratory, Emory Medical Laboratory, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Special Coagulation Laboratory, Emory Medical Laboratory, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103142131","display_name":"Adam Webb","orcid":"https://orcid.org/0000-0002-3717-8801","observed_orcids":["https://orcid.org/0000-0002-3717-8801"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Webb","raw_affiliation_strings":["Departments of Neurology and Neurosurgery, Emory University School of Medicine, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neurology and Neurosurgery, Emory University School of Medicine, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009837594","display_name":"Sean R. Stowell","orcid":"https://orcid.org/0000-0002-1130-9551","observed_orcids":["https://orcid.org/0000-0002-1130-9551"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean R. Stowell","raw_affiliation_strings":["Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050971423","display_name":"John D. Roback","orcid":"https://orcid.org/0000-0001-9952-2252","observed_orcids":["https://orcid.org/0000-0001-9952-2252"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John D. Roback","raw_affiliation_strings":["Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5021756706"],"corresponding_institution_ids":["https://openalex.org/I150468666"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":1.626,"has_fulltext":true,"cited_by_count":19,"citation_normalized_percentile":{"value":0.84792611,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"94","issue":"5","first_page":"E132","last_page":"E134"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.5532000064849854,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.5532000064849854,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.3582000136375427,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.04390000179409981,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9020000100135803},{"id":"https://openalex.org/keywords/factor-xa-inhibitors","display_name":"factor Xa inhibitors","score":0.8859999775886536},{"id":"https://openalex.org/keywords/anti-xa-assay","display_name":"anti-Xa assay","score":0.8489999771118164},{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":0.8999999761581421},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":1.0},{"id":"https://openalex.org/keywords/andexanet-alfa","display_name":"andexanet alfa","score":0.9580000042915344},{"id":"https://openalex.org/keywords/assay-correlation","display_name":"assay correlation","score":0.42100000381469727},{"id":"https://openalex.org/keywords/bleeding-reversal","display_name":"bleeding reversal","score":0.35499998927116394},{"id":"https://openalex.org/keywords/laboratory-developed-tests","display_name":"laboratory-developed tests","score":0.6589999794960022},{"id":"https://openalex.org/keywords/turnaround-time","display_name":"turnaround time","score":0.5559999942779541},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.6349999904632568},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.49799999594688416},{"id":"https://openalex.org/keywords/coagulation-monitoring","display_name":"coagulation monitoring","score":0.5170000195503235},{"id":"https://openalex.org/keywords/point-of-care-testing","display_name":"point-of-care testing","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.6528580784797668},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6312187314033508},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5632273554801941},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5155829787254333},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.42319658398628235},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20837736129760742},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.12289077043533325},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D001780","descriptor_name":"Blood Coagulation Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/ajh.25434","doi":"https://doi.org/10.1002/ajh.25434","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ajh.25434","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.25434","source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},{"id":"pmid:30734369","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30734369","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of hematology","raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:8668051","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8668051","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Am J Hematol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/ajh.25434","doi":"https://doi.org/10.1002/ajh.25434","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ajh.25434","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.25434","source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000876271","display_name":"Training Grant in Transfusion Medicine","funder_award_id":"T32HL069769","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2913106735.pdf","grobid_xml":"https://content.openalex.org/works/W2913106735.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W2114338695","https://openalex.org/W2198635349","https://openalex.org/W2277250099","https://openalex.org/W2514338974","https://openalex.org/W2617725726","https://openalex.org/W2892153557"],"related_works":["https://openalex.org/W3171527403","https://openalex.org/W3097292262","https://openalex.org/W3013260441","https://openalex.org/W3203307769","https://openalex.org/W3096798015","https://openalex.org/W2342429001","https://openalex.org/W3191787166","https://openalex.org/W4391921624","https://openalex.org/W2986482963","https://openalex.org/W4223642344"],"abstract_inverted_index":{"The":[0,481,624,1014,1049],"much-anticipated":[1],"arrival":[2],"of":[3,18,77,98,115,146,161,201,233,260,262,279,296,319,327,366,383,392,484,518,530,579,666,747,863,1000,1008],"andexanet":[4],"alfa,":[5],"a":[6,202,214,230,276,346,416,468,474,612,715,901],"recombinant":[7],"factor":[8,21],"Xa":[9,22],"decoy":[10],"protein":[11],"that":[12,126,894,945],"rapidly":[13],"reverses":[14],"the":[15,83,112,250,292,325,364,367,377,389,438,446,464,478,514,531,553,557,580,595,606,667,685,698,709,732,741,827,845,860,1029,1071,1088],"anticoagulant":[16],"effects":[17],"direct":[19],"oral":[20],"inhibitors":[23],"(FXai)":[24],"like":[25,152],"apixaban":[26,401,422,482,607,795,811],"and":[27,80,86,143,155,163,236,307,334,337,353,402,410,430,443,473,520,545,556,618,657,677,688,721,737,767,807,848,914,970,973,981,1010,1021,1038,1046,1060,1067,1078,1085],"rivaroxaban,1":[28],"has":[29,314],"many":[30,136,188],"hospital":[31],"systems":[32],"wondering":[33],"how":[34],"to":[35,56,105,246,271,289,323,354,496,567,575,586,639,740,788,831,943,1003,1017],"manage":[36],"patients":[37,50,384,491,631,756,769,803,818,855,932],"who":[38],"may":[39,59,139,240,360,874,883,899],"benefit":[40],"from":[41,219,488,493,524,628,636,660],"reversal":[42],"but":[43],"fall":[44],"outside":[45],"clear":[46,934],"indications.":[47],"For":[48,206],"example,":[49,207],"with":[51,275,376,437,590,603,706,757,773,804,856,1043],"delayed":[52],"drug":[53,358,762],"clearance":[54],"due":[55],"renal":[57],"failure":[58],"experience":[60,987],"major":[61],"bleeding":[62,759,777],"or":[63,175,197,294,796,812,996],"require":[64],"emergent":[65],"surgery.":[66],"A":[67],"recent":[68],"perspective":[69],"article":[70],"in":[71,93,135,166,213,257,303,340,374,399,768,802,817,826,903,1005,1028,1064],"Blood":[72],"provides":[73],"an":[74,395],"excellent":[75,1025],"overview":[76],"FXai":[78,91,107,147,211,273,305,357,387,588,761,857,905,937,1001,1012],"testing":[79,92,196,212,456,866,898,909,994,1002],"highlights":[81],"both":[82,335],"limited":[84,162,199,566],"availability":[85,200],"clinical":[87,851],"need":[88],"for":[89,244,291,421,745,755,776,794,800,810,815,850,854,936,950,1024,1041],"drug-specific":[90,100,176,183,195,881,908,955],"critical":[94],"situations.2":[95],"While":[96],"development":[97],"rapid":[99,915],"assays":[101,184,285,339,879,947,956],"is":[102,254,565,910,918],"underway,":[103],"methods":[104,999],"quantitate":[106],"concentrations":[108,729,763,779],"quickly,":[109],"especially":[110],"given":[111,613,844,968],"high":[113,774],"cost":[114],"antidote,":[116],"are":[117,160,170,185,268,889,957,964],"needed":[118],"right":[119],"now.":[120],"Herein,":[121],"we":[122,321,569,941,984],"provide":[123],"data":[124,892,963,1047,1065],"suggesting":[125],"conventional":[127,895],"heparin-calibrated":[128,251,368,454,558,581,946],"anti-Xa":[129,178,252,284,332,418,441,455,471,509,559,615,652,690,718,790,865,897,929],"tests,":[130],"performed":[131,444,458,571],"using":[132,173,311,363,415,467,535,880],"standard":[133],"coagulometers":[134],"U.S.":[137],"hospitals,":[138],"help":[140],"guide":[141],"appropriate":[142],"cost-effective":[144],"use":[145],"antidote.":[148,1013],"Routine":[149],"coagulation":[150,217,1031],"tests":[151],"prothrombin":[153],"time":[154,159,232,278,917],"activated":[156],"partial":[157],"thromboplastin":[158],"variable":[164,301],"utility":[165],"measuring":[167],"FXai,":[168,297],"which":[169,267,1074],"best":[171],"quantified":[172],"molecular":[174],"chromogenic":[177,283,417],"assays.":[179],"As":[180,563],"no":[181,308,1052],"FDA-approved":[182],"commercially":[186],"available,":[187],"US":[189],"hospitals":[190],"either":[191],"do":[192,922,940],"not":[193,241,269,841,870,911,923,965],"offer":[194],"have":[198,229,286,299,900,1051],"\"Laboratory":[203],"Developed":[204],"Test.\"":[205],"our":[208,263,330,341,784,834,962,986],"institution":[209],"offers":[210],"dedicated":[215],"special":[216,1030],"laboratory":[218,975],"Monday":[220],"through":[221],"Friday":[222],"during":[223],"normal":[224],"business":[225],"hours.":[226],"STAT":[227],"specimens":[228,393,462,534,670],"turnaround":[231,277,916],"4":[234],"hours,":[235],"those":[237],"received":[238],"after-hours":[239],"be":[242,361,584,824,842,884,948],"resulted":[243],"up":[245],"3":[247],"days.":[248],"However,":[249],"assay":[253,333,419,555,582],"available":[255,913],"24/7":[256],"five":[258],"out":[259],"six":[261],"health-system":[264],"core":[265],"laboratories,":[266],"staffed":[270],"handle":[272],"calibration,":[274],"<1":[280,637],"hour.":[281],"Heparin-calibrated":[282],"been":[287,315],"used":[288,585,949],"screen":[290],"presence":[293],"absence":[295],"yet":[298],"shown":[300],"effectiveness":[302],"quantifying":[304],"levels":[306,359,412,500,589,634,643,791,858,906],"robust":[309],"study":[310],"patient":[312,342],"samples":[313,487,626],"reported.3-5":[316],"In":[317,960],"light":[318],"this,":[320],"sought":[322],"establish":[324,977],"strength":[326],"correlation":[328,526,529,551,564,662,665,683],"between":[329,552,684,992],"heparin":[331,475,508,614,651,689,717,789,864,896],"apixaban-":[336],"rivaroxaban-specific":[338],"population":[343],"by":[344,611,714,731,833,1080],"completing":[345],"full":[347],"(n":[348,503,646],"\u2265":[349],"120)":[350],"validation":[351],"study,":[352],"determine":[355,576],"if":[356],"predicted":[362,610,713],"results":[365,510,578,653,930],"assay.":[369],"Institutional":[370],"guidelines":[371],"were":[372,413,521,658,869,1062],"followed":[373],"accordance":[375],"institutional":[378],"review":[379],"board":[380],"determination.":[381],"Queries":[382],"actively":[385],"taking":[386],"identified":[388],"target":[390],"number":[391],"within":[394],"8-week":[396],"period,":[397],"resulting":[398],"121":[400,485],"120":[403,625],"rivaroxaban":[404,411,431,633,686,710,801,816],"leftover/discarded":[405],"random-collection-citrated":[406],"plasma":[407],"samples.":[408],"Apixaban":[409,424],"determined":[414],"calibrated":[420],"(Biophen":[423,432],"Calibrator":[425,434],"kit,":[426],"Hyphen":[427],"BioMed,":[428],"France)":[429],"Rivaroxaban":[433],"kit),":[435],"respectively,":[436],"HemosIL":[439,469],"liquid":[440,470],"reagent":[442,472,969],"on":[445,459,477,735,1077],"ACL-TOP":[447,479],"instrument":[448],"(Instrumentation":[449],"Laboratory,":[450],"Bedford,":[451],"Massachusetts).":[452],"Conventional":[453],"was":[457,1075],"all":[460,1081],"241":[461],"following":[463],"manufacturer's":[465],"instructions":[466],"calibrator":[476],"instrument.":[480],"level":[483,608,616,687,711,719],"unique":[486],"76":[489],"apixaban-treated":[490],"ranged":[492],"<13":[494],"ng/mL":[495,502,638,645,766],">600":[497],"ng/mL.":[498,641],"All":[499,642],"\u2265268":[501],"=":[504,548,599,647,680,702],"18)":[505],"had":[506,649],"corresponding":[507,650],"over":[511,654],"2.0":[512,655],"IU/mL,":[513],"assay's":[515],"upper":[516],"limit":[517],"detection,":[519],"thus":[522],"excluded":[523,659],"linear":[525,572,661,861],"analysis.":[527,663,1068],"Pearson's":[528,664],"remaining":[532,668],"103":[533],"GraphPad":[536],"Prism":[537],"(Carlsbad,":[538],"CA)":[539],"demonstrated":[540,672],"significant":[541,673],"(P":[542,674],"<":[543,620,675,723],"0.0001)":[544,676],"strong":[546,678],"(R2":[547,679],"0.9662)":[549],"positive":[550,682],"apixaban-specific":[554],"test":[560],"(Figure":[561,622,692,725],"1A).":[562,623],"association,":[568],"also":[570],"regression":[573,695],"analysis":[574,593,696],"whether":[577],"could":[583],"predict":[587],"significance.":[591],"Such":[592],"generated":[594,697],"best-fit":[596,699],"equation":[597,700],"Y":[598,604,701,707],"119.2X":[600],"+":[601,704],"11,":[602],"representing":[605,708],"(ng/ml)":[609,712],"(X)":[617,720],"P":[619,722],"0.0001":[621,724],"obtained":[627],"82":[629],"rivaroxaban-treated":[630],"revealed":[632],"ranging":[635],">500":[640],"\u2265240":[644],"21)":[648],"IU/mL":[656,793,799,809,814],"99":[669],"likewise":[671],"0.9755)":[681],"result":[691],"1B).":[693,726],"Linear":[694],"125.1X":[703],"4.29,":[705],"certain":[716],"Applying":[727],"threshold":[728],"proposed":[730],"International":[733],"Society":[734],"Thrombosis":[736],"Haemostasis":[738],"(ISTH)":[739],"above":[742,780],"equations":[743],"allows":[744],"determination":[746],"cut-off":[748],"values.":[749],"Specifically,":[750],"ISTH":[751],"recommends":[752],"antidote":[753],"consideration":[754],"serious":[758,805],"when":[760,886,907,931,954],"exceed":[764],"50":[765],"requiring":[770,819],"urgent":[771],"intervention":[772],"risk":[775],"at":[778],"30":[781],"ng/mL.6":[782],"Using":[783],"data,":[785],"this":[786,876],"corresponds":[787],">0.33":[792],">":[797],"0.37":[798],"bleeding,":[806],">0.16":[808],">0.21":[813],"intervention.":[820],"This":[821],"information":[822],"will":[823,840],"included":[825],"interpretive":[828],"comment":[829],"provided":[830],"practitioners":[832],"laboratory,":[835,1032],"although":[836],"strict":[837],"cutoff":[838],"values":[839,888],"recommended":[843],"limitations":[846],"described":[847],"importance":[849],"correlation.":[852],"Results":[853],"exceeding":[859],"range":[862],"(>2.0":[867],"IU/mL)":[868],"determined.":[871],"Sample":[872],"dilution":[873],"overcome":[875],"limitation;":[877],"however,":[878],"calibration":[882],"warranted":[885],"exact":[887],"necessary.":[890],"Our":[891],"suggest":[893,944],"role":[902],"assessing":[904],"readily":[912],"required.":[919],"We":[920],"certainly":[921],"advocate":[924],"delaying":[925],"treatment":[926],"while":[927],"awaiting":[928],"meet":[933],"indications":[935],"reversal,":[938],"nor":[939],"mean":[942],"nonurgent":[951],"pharmacokinetic":[952],"studies":[953],"more":[958],"appropriate.":[959],"addition,":[961],"necessarily":[966],"generalizable":[967],"coagulometer":[971],"variability,":[972],"each":[974],"should":[976],"their":[978,993],"own":[979],"cut-offs":[980],"ranges.":[982],"Nevertheless,":[983],"hope":[985],"helps":[988],"others":[989],"investigate":[990],"correlations":[991],"platforms":[995],"other":[997],"alternative":[998],"aid":[1004],"optimal":[1006],"utilization":[1007],"new":[1009],"expensive":[1011],"authors":[1015,1050],"wish":[1016],"thank":[1018],"Eileen":[1019],"Barrette":[1020],"Juli":[1022],"Buchanan":[1023],"technical":[1026],"assistance":[1027,1042],"as":[1033,1035],"well":[1034],"Missy":[1036],"Pearson":[1037],"Melody":[1039],"Tsao":[1040],"specimen":[1044],"identification":[1045],"acquisition.":[1048],"competing":[1053],"financial":[1054],"interests.":[1055],"CLM,":[1056,1083],"WHA,":[1057],"AD,":[1058,1084],"AR,":[1059],"AI":[1061],"involved":[1063],"acquisition":[1066],"CLM":[1069],"wrote":[1070],"initial":[1072],"manuscript,":[1073],"commented":[1076],"edited":[1079],"authors.":[1082],"JR":[1086],"oversaw":[1087],"experimental":[1089],"design.":[1090]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-02-21T00:00:00"}